Dow Jones U.S. Pharmaceuticals Index


D.J. US Pharmaceutical Top 10: Value Investment Strategy

TOP 10 Value INDUSTRY VALUE GROWTH SAFETY COMBINED
1. Pfizer (XL, US) Pharmaceuticals
75
12
99
84
2. Merck (XL, US) ☀ Pharmaceuticals
75
14
86
77
3. Depomed (XS, US) Pharmaceuticals
73
98
4
78
4. Heska (XS, US) Pharmaceuticals
73
83
2
66
5. Endocyte (XS, US) Pharmaceuticals
63
47
61
71
6. Sagent (XS, US) Pharmaceuticals
62
35
62
65
7. Johnson & Johnson (XL, US) ☀ Pharmaceuticals
61
52
42
55
8. SciClone (XS, US) Pharmaceuticals
60
80
76
98
9. Hospira (M, US) Pharmaceuticals
53
83
53
83
10. Lannett (S, US) Pharmaceuticals
50
100
62
75

January 2, 2015. Top 10s are published weekly by . ()


D.J. US Pharmaceutical Top 10: Growth Investment Strategy

TOP 10 Growth INDUSTRY VALUE GROWTH SAFETY COMBINED
1. Lannett (S, US) Pharmaceuticals
50
100
62
75
2. Depomed (XS, US) Pharmaceuticals
73
98
4
78
3. Pacira Pharma (S, US) Pharmaceuticals
1
98
55
63
4. Pernix Therapeutics (XS, US) Pharmaceuticals
14
98
4
18
5. Akorn (M, US) Pharmaceuticals
2
98
4
13
6. Nektar (S, US) Pharmaceuticals
4
95
36
43
7. Supernus Pharma (S, US) Pharmaceuticals
49
90
92
98
8. Impax (S, US) Pharmaceuticals
42
85
70
90
9. Hospira (M, US) Pharmaceuticals
53
83
53
83
10. Heska (XS, US) Pharmaceuticals
73
83
2
66

January 2, 2015. Top 10s are published weekly by . ()


D.J. US Pharmaceutical Top 10: Safety Investment Strategy

TOP 10 Safety INDUSTRY VALUE GROWTH SAFETY COMBINED
1. Vivus (XS, US) Pharmaceuticals
26
71
100
90
2. Pfizer (XL, US) Pharmaceuticals
75
12
99
84
3. Bristol-Myers Squibb (XXL, US) ☀ Pharmaceuticals
21
36
97
55
4. Supernus Pharma (S, US) Pharmaceuticals
49
90
92
98
5. Merck (XL, US) ☀ Pharmaceuticals
75
14
86
77
6. SciClone (XS, US) Pharmaceuticals
60
80
76
98
7. Impax (S, US) Pharmaceuticals
42
85
70
90
8. Eli Lilly (XL, US) ☀ Pharmaceuticals
45
22
66
38
9. Lannett (S, US) Pharmaceuticals
50
100
62
75
10. Sagent (XS, US) Pharmaceuticals
62
35
62
65

January 2, 2015. Top 10s are published weekly by . ()


D.J. US Pharmaceutical Top 10: Combined Investment Strategy

TOP 10 Combined INDUSTRY VALUE GROWTH SAFETY COMBINED
1. Supernus Pharma (S, US) Pharmaceuticals
49
90
92
98
2. SciClone (XS, US) Pharmaceuticals
60
80
76
98
3. Impax (S, US) Pharmaceuticals
42
85
70
90
4. Vivus (XS, US) Pharmaceuticals
26
71
100
90
5. Pfizer (XL, US) Pharmaceuticals
75
12
99
84
6. Hospira (M, US) Pharmaceuticals
53
83
53
83
7. Depomed (XS, US) Pharmaceuticals
73
98
4
78
8. Merck (XL, US) ☀ Pharmaceuticals
75
14
86
77
9. Lannett (S, US) Pharmaceuticals
50
100
62
75
10. Endocyte (XS, US) Pharmaceuticals
63
47
61
71

January 2, 2015. Top 10s are published weekly by . ()

☀ This company has a special achievement which is documented on its stock research page.

Top 10 lists may contain fewer then 10 stocks due to Obermatt’s top 10 quality standards.

All Top 10 Lists
Method
Free Stock Update

Top 10 Stocks from the purely finance fact-based Obermatt Method for the investment strategies Value, Growth and Safety in the stock index Dow Jones U.S. Pharmaceuticals Index from January 2, 2015.

Top 10 Stock History D.J. US Pharmaceutical